Similar articles

• Thrombolytic therapy for myocardial infarction.

  Guerci AD. Guerci AD. Md Med J. 1990 Apr;39(4):377-81. Md Med J. 1990. PMID: 2110282
• What you should know about thrombolytic therapy for acute MI.

  Aragon D, Martin M. Aragon D, et al. Am J Nurs. 1993 Sep;93(9):24-31; quiz 33. Am J Nurs. 1993. PMID: 8213959 Review. No abstract available.
• GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

  [No authors listed] [No authors listed] Lancet. 1990 Jul 14;336(8707):65-71. Lancet. 1990. PMID: 1975321 Clinical Trial.
• Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist.

  Vogel JH. Vogel JH. Clin Cardiol. 1991 Jul;14(7):548. Clin Cardiol. 1991. PMID: 1810292 No abstract available.
• [t-PA in thrombolytic therapy of acute myocardial infarct].

  Rutsch W, Schmutzler H. Rutsch W, et al. Herz. 1994 Dec;19(6):336-52. Herz. 1994. PMID: 7843690 Review. German.